Efficacy and safety of nafamostat mesilate anticoagulation in blood purification treatment of critically ill patients: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Efficacy and safety of nafamostat mesilate anticoagulation in blood purification treatment of critically ill patients: a systematic review and meta-analysis

Published:2022-08-05 Issue:1 Volume:44 Page:1264-1280
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Lin Yao¹^ORCID,Shao Yiming²,Liu Yuchun¹,Yang Ruoxuan¹,Liao Shuanglin²,Yang Shuai²,Xu Mingwei¹,He Junbing¹^ORCID

Affiliation:

1. Jieyang Medical Research Center, Jieyang People's Hospital, Jieyang, China

2. The Intensive Care Unit, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, China

Funder

Guangdong Province Science and Technology Special Fund of Major Projects and Task List in Jieyang City

Novel Coronavirus Infection Prevention technology and product project of Zhanjiang City

Publisher

Informa UK Limited

Subject

Nephrology,Critical Care and Intensive Care Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0886022X.2022.2105233

Reference66 articles.

1. What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2

2. Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU

3. Extracorporeal Blood Purification and Organ Support in the Critically Ill Patient during COVID-19 Pandemic: Expert Review and Recommendation

4. Blood purification therapy with a hemodiafilter featuring enhanced adsorptive properties for cytokine removal in patients presenting COVID-19: a pilot study

5. Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to safeguard the continuous renal replacement therapy circuit: a narrative review;Frontiers in Medicine;2024-08-21

2. Dose of nafamostat mesylate during continuous kidney replacement therapy in critically ill patients: a two-centre observational study;BMC Nephrology;2024-02-26

3. Efficacy and safety of Nafamostat mesylate in patients with end-stage renal failure;World Journal of Clinical Cases;2024-01-06

4. A case of acute spinal epidural hematoma with chronic kidney disease, which was relieved by prompt surgery;Nihon Toseki Igakkai Zasshi;2024

5. Filter Lifespan, Treatment Effect, and Influencing Factors of Continuous Renal Replacement Therapy for Severe Burn Patients;Journal of Burn Care & Research;2023-12-19